Eko Murmur Analysis Software (EMAS) vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

These two FDA-cleared cardiology AI tools offer adjacent but distinct diagnostic capabilities. Eko Murmur Analysis Software (EMAS) focuses on detecting and differentiating heart murmurs from auscultated heart sounds, integrating with digital stethoscopes. In contrast, the AI-ECG Platform specializes in the automatic analysis and diagnosis of 12-lead resting ECGs for a broader range of cardiovascular conditions.

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if you are a clinician using Eko digital stethoscopes and require AI-powered assistance for real-time detection and differentiation of heart murmurs in both adult and pediatric patients. This tool is ideal for point-of-care clinical decision support, leveraging heart sound analysis via a mobile application to help distinguish between innocent and structural murmurs.

View Eko Murmur Analysis Software (EMAS) →

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your practice or institution needs a highly accurate, hardware-independent AI system for the rapid, automatic analysis and diagnosis of 12-lead resting ECGs. This platform is best suited for comprehensive interpretation of various cardiovascular conditions, including arrhythmias, myocardial ischemia, and infarction, across multiple ECG machine types, with deployment options for workstations and web-based access.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Murmur Analysis Software (EMAS) AI-ECG Platform
Pricing Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. Contact for pricing
Deployment Cloud-based, Mobile App Workstation (with GPU), web-based portal, Windows-based diagnostic client
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) offers a streamlined, mobile-first user experience by integrating directly with Eko digital stethoscopes and utilizing a mobile application for recording, playback, and report generation. This approach simplifies the workflow at the point of care. While Tool B offers deployment flexibility, its workstation and Windows client options may introduce more complexity compared to Tool A's integrated mobile solution.

Clinical Value

AI-ECG Platform

Both tools are FDA-cleared and provide significant clinical value. However, Tool B (AI-ECG Platform) offers a broader diagnostic scope by analyzing 12-lead resting ECGs for a wider range of major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with over 95% accuracy. Tool A focuses specifically on detecting and differentiating heart murmurs, which is valuable but narrower in scope compared to comprehensive ECG analysis.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) provides a transparent pricing model with a free basic AI analysis tier, making it accessible for initial use and offering clear value propositions for its paid subscriptions. In contrast, Tool B (AI-ECG Platform) requires users to contact for pricing, which lacks transparency and makes it difficult to assess its value without direct engagement.

Enterprise Readiness

AI-ECG Platform

Tool B (AI-ECG Platform) demonstrates stronger enterprise readiness through its support for various standard ECG data formats (HL7 aECG, DICOM ECG, SCP ECG, MFER ECG) and its explicit mention of a web-based Management Portal for organization settings, security, and task management. These features indicate a more robust capability for integration into diverse healthcare IT environments and centralized management.

Innovation

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) exhibits a higher degree of innovation by integrating AI directly with digital stethoscopes for real-time, point-of-care murmur detection and differentiation. This hardware-software synergy provides immediate clinical decision support in a novel and accessible form factor. While Tool B offers high accuracy and speed in ECG analysis, the direct integration of AI with a physical diagnostic tool for real-time feedback is a more distinct innovation in workflow.

Support & Docs

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) has a robust and easily accessible support infrastructure, including a comprehensive online help center with FAQs, user manuals, troubleshooting guides, and multiple contact options for customer support. Tool B (AI-ECG Platform) lacks readily available public documentation or a dedicated support portal, making it harder for users to find information or get assistance independently.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Murmur Analysis Software (EMAS) AI-ECG Platform
Name Eko Murmur Analysis Software (EMAS) AI-ECG Platform
Company Eko Devices Shenzhen Carewell Electronics Co., Ltd.
Description Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
Primary Data Analyzed Heart sound (PCG) and optional ECG data 12-lead resting ECGs
Key Features (Examples) FDA-cleared AI for murmur detection, Differentiates innocent and structural heart murmurs, Integrates with Eko digital stethoscopes AI-powered automatic ECG analysis and diagnosis, Over 95% accuracy in diagnosing major cardiovascular diseases, Hardware independent, compatible with most ECG machines

Videos

Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and AI-ECG Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Murmur Analysis Software (EMAS) is designed to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. The AI-ECG Platform, on the other hand, is an AI automatic analysis and diagnosis system for ECG, assisting physicians in interpreting 12-lead resting ECGs to diagnose arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
EMAS analyzes heart sound (PCG) and optional ECG data, and integrates with Eko digital stethoscopes (CORE 500, DUO, CORE). The AI-ECG Platform analyzes 12-lead resting ECG data and is hardware independent, compatible with most ECG machines.
Eko Murmur Analysis Software (EMAS) is FDA-cleared for detecting and characterizing murmurs in both adult and pediatric patients. The AI-ECG Platform is qualified for use in the general adult population, ranging from healthy subjects to patients with cardiac and/or non-cardiac abnormalities.
Eko Murmur Analysis Software (EMAS) displays analysis results on the Eko mobile application in less than 10 seconds after a recording of at least 5 seconds is completed. The AI-ECG Platform provides rapid diagnosis in approximately 3 seconds.

Backers

Who funded each tool's parent company.

Eko Murmur Analysis Software (EMAS)

AI Tool Finder
AI-powered search. Results may not be comprehensive.